Key facts
- BigOmics Analytics’s last known valuation is $12.8M (Mar 2022).
- It has raised $4.6M; the latest was Later Stage VC ($1.6M) in Oct 2025.
- Notable investors include Alchemist Accelerator, Acequia Capital, Champion Hill Ventures, ADM Partners (VC), Century Oak Ventures — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for BigOmics Analytics
- ·The full record, as it builds
Funding rounds
No funding rounds for BigOmics Analytics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BigOmics Analytics
Developer of a data analytics platform designed to create smart tools and make health analysis accessible to everyone. The company's platform provides biologists, bioinformaticians, and life scientists with the ability to analyze and build dashboards to explore data and manage data queries, enabling healthcare professionals to get self-service bioinformatics to fast-track the patient's bioinformatics needs.
- Sector
- Healthcare
- HQ
- Lugano, Switzerland
- Employees
- 14
- Website
- bigomics.ch/
- Ownership
- Privately Held (backing)
BigOmics Analytics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BigOmics Analytics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BigOmics Analytics in its N-PORT filings yet. We sweep new filings monthly.